Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.
Identifieur interne : 000913 ( PubMed/Curation ); précédent : 000912; suivant : 000914Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.
Auteurs : A O Shittu ; H O Olawumi ; J O AdewuyiSource :
- Ghana medical journal [ 0016-9560 ] ; 2014.
Descripteurs français
- KwdFr :
- Analyse coût-bénéfice, Banques de sang (), Banques de sang (économie), Donneurs de sang, Dépistage systématique (), Dépistage systématique (économie), Humains, Hépatite B (), Hépatite B (transmission), Hépatite C (), Hépatite C (transmission), Infections à VIH (), Infections à VIH (transmission), Nigeria, Pathogènes transmissibles par le sang, Pays en voie de développement, Sécurité transfusionnelle (), Sécurité transfusionnelle (économie), Transfusion sanguine (effets indésirables), Études rétrospectives.
- MESH :
- effets indésirables : Transfusion sanguine.
- économie : Banques de sang, Dépistage systématique, Hépatite B, Hépatite C, Infections à VIH, Sécurité transfusionnelle.
- Analyse coût-bénéfice, Banques de sang, Donneurs de sang, Dépistage systématique, Humains, Hépatite B, Hépatite C, Infections à VIH, Nigeria, Pathogènes transmissibles par le sang, Pays en voie de développement, Sécurité transfusionnelle, Études rétrospectives.
- Wicri :
- geographic : Nigeria.
English descriptors
- KwdEn :
- Blood Banks (economics), Blood Banks (methods), Blood Donors, Blood Safety (economics), Blood Safety (methods), Blood Transfusion (adverse effects), Blood-Borne Pathogens, Cost-Benefit Analysis, Developing Countries, HIV Infections (prevention & control), HIV Infections (transmission), Hepatitis B (prevention & control), Hepatitis B (transmission), Hepatitis C (prevention & control), Hepatitis C (transmission), Humans, Mass Screening (economics), Mass Screening (methods), Nigeria, Retrospective Studies.
- MESH :
- geographic : Nigeria.
- adverse effects : Blood Transfusion.
- economics : Blood Banks, Blood Safety, Mass Screening.
- methods : Blood Banks, Blood Safety, Mass Screening.
- prevention & control : HIV Infections, Hepatitis B, Hepatitis C.
- transmission : HIV Infections, Hepatitis B, Hepatitis C.
- Blood Donors, Blood-Borne Pathogens, Cost-Benefit Analysis, Developing Countries, Humans, Retrospective Studies.
Abstract
To determine whether or not pre-donation testing of blood donors affords substantial cost savings without compromise to blood transfusion safety. Pre-donation testing of blood donors for Transfusion Transmissible Infections (TTIs) is done in most developing countries because substantial cost savings are made from resources, materials and man-hours which would have been spent to procure infected blood units. Simple rapid test kits used in pre-donation testing is not as sensitive as the Enzyme Linked Immuno-sorbent Assay (ELISA) method used in post-donation screening in a quality assured manner.
PubMed: 25709126
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000914
Links to Exploration step
pubmed:25709126Curation
No country items
A O Shittu<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.</title>
<author><name sortKey="Shittu, A O" sort="Shittu, A O" uniqKey="Shittu A" first="A O" last="Shittu">A O Shittu</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Olawumi, H O" sort="Olawumi, H O" uniqKey="Olawumi H" first="H O" last="Olawumi">H O Olawumi</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adewuyi, J O" sort="Adewuyi, J O" uniqKey="Adewuyi J" first="J O" last="Adewuyi">J O Adewuyi</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25709126</idno>
<idno type="pmid">25709126</idno>
<idno type="wicri:Area/PubMed/Corpus">000914</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000914</idno>
<idno type="wicri:Area/PubMed/Curation">000913</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000913</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.</title>
<author><name sortKey="Shittu, A O" sort="Shittu, A O" uniqKey="Shittu A" first="A O" last="Shittu">A O Shittu</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Olawumi, H O" sort="Olawumi, H O" uniqKey="Olawumi H" first="H O" last="Olawumi">H O Olawumi</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Adewuyi, J O" sort="Adewuyi, J O" uniqKey="Adewuyi J" first="J O" last="Adewuyi">J O Adewuyi</name>
<affiliation><nlm:affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</nlm:affiliation>
<wicri:noCountry code="subField">University of Ilorin</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Ghana medical journal</title>
<idno type="ISSN">0016-9560</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Banks (economics)</term>
<term>Blood Banks (methods)</term>
<term>Blood Donors</term>
<term>Blood Safety (economics)</term>
<term>Blood Safety (methods)</term>
<term>Blood Transfusion (adverse effects)</term>
<term>Blood-Borne Pathogens</term>
<term>Cost-Benefit Analysis</term>
<term>Developing Countries</term>
<term>HIV Infections (prevention & control)</term>
<term>HIV Infections (transmission)</term>
<term>Hepatitis B (prevention & control)</term>
<term>Hepatitis B (transmission)</term>
<term>Hepatitis C (prevention & control)</term>
<term>Hepatitis C (transmission)</term>
<term>Humans</term>
<term>Mass Screening (economics)</term>
<term>Mass Screening (methods)</term>
<term>Nigeria</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Banques de sang ()</term>
<term>Banques de sang (économie)</term>
<term>Donneurs de sang</term>
<term>Dépistage systématique ()</term>
<term>Dépistage systématique (économie)</term>
<term>Humains</term>
<term>Hépatite B ()</term>
<term>Hépatite B (transmission)</term>
<term>Hépatite C ()</term>
<term>Hépatite C (transmission)</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (transmission)</term>
<term>Nigeria</term>
<term>Pathogènes transmissibles par le sang</term>
<term>Pays en voie de développement</term>
<term>Sécurité transfusionnelle ()</term>
<term>Sécurité transfusionnelle (économie)</term>
<term>Transfusion sanguine (effets indésirables)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Nigeria</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Blood Transfusion</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Blood Banks</term>
<term>Blood Safety</term>
<term>Mass Screening</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transfusion sanguine</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Banks</term>
<term>Blood Safety</term>
<term>Mass Screening</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Banques de sang</term>
<term>Dépistage systématique</term>
<term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
<term>Sécurité transfusionnelle</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Blood Donors</term>
<term>Blood-Borne Pathogens</term>
<term>Cost-Benefit Analysis</term>
<term>Developing Countries</term>
<term>Humans</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Banques de sang</term>
<term>Donneurs de sang</term>
<term>Dépistage systématique</term>
<term>Humains</term>
<term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
<term>Nigeria</term>
<term>Pathogènes transmissibles par le sang</term>
<term>Pays en voie de développement</term>
<term>Sécurité transfusionnelle</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Nigeria</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To determine whether or not pre-donation testing of blood donors affords substantial cost savings without compromise to blood transfusion safety. Pre-donation testing of blood donors for Transfusion Transmissible Infections (TTIs) is done in most developing countries because substantial cost savings are made from resources, materials and man-hours which would have been spent to procure infected blood units. Simple rapid test kits used in pre-donation testing is not as sensitive as the Enzyme Linked Immuno-sorbent Assay (ELISA) method used in post-donation screening in a quality assured manner.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25709126</PMID>
<DateCreated><Year>2015</Year>
<Month>02</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>10</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-9560</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>48</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Ghana medical journal</Title>
<ISOAbbreviation>Ghana Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.</ArticleTitle>
<Pagination><MedlinePgn>158-62</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether or not pre-donation testing of blood donors affords substantial cost savings without compromise to blood transfusion safety. Pre-donation testing of blood donors for Transfusion Transmissible Infections (TTIs) is done in most developing countries because substantial cost savings are made from resources, materials and man-hours which would have been spent to procure infected blood units. Simple rapid test kits used in pre-donation testing is not as sensitive as the Enzyme Linked Immuno-sorbent Assay (ELISA) method used in post-donation screening in a quality assured manner.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">It is a retrospective study where records of pre- and post-donation tests done in donor clinic of University of Ilorin Teaching Hospital, between January and December 2010 were retrieved. All processes and inputs were evaluated and costs calculated for pre-donation testing by simple rapid techniques and post donation screening by ELISA.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">5000 prospective donors were tested in the study period. The cost of single rapid Pre-donation testing was less than that of single ELISA Post-donation screen. The cost of double rapid Pre-donation and Post donation ELISA screen exceeded the cost of single post donation ELISA screen. Substantial cost savings were made when single rapid Pre-donation testing is relied on. More blood units were found reactive for the TTIs with the more expensive Post-donation ELISA.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pre-donation testing of blood donors was not cost effective. Although, there is an apparent savings if pre-donation testing is not followed by post-donation ELISA testing, it is done at a compromise to blood transfusion safety.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shittu</LastName>
<ForeName>A O</ForeName>
<Initials>AO</Initials>
<AffiliationInfo><Affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Olawumi</LastName>
<ForeName>H O</ForeName>
<Initials>HO</Initials>
<AffiliationInfo><Affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Adewuyi</LastName>
<ForeName>J O</ForeName>
<Initials>JO</Initials>
<AffiliationInfo><Affiliation>Department of Haematology and Blood Transfusion, University of Ilorin.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Ghana</Country>
<MedlineTA>Ghana Med J</MedlineTA>
<NlmUniqueID>0073210</NlmUniqueID>
<ISSNLinking>0016-9560</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1996 Jun 27;334(26):1685-90</RefSource>
<PMID Version="1">8637512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Transfus Med Rev. 1997 Jul;11(3):155-72</RefSource>
<PMID Version="1">9243769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Virol J. 2011;8:105</RefSource>
<PMID Version="1">21385397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intern Med J. 2005 Oct;35(10):592-8</RefSource>
<PMID Version="1">16207258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Transfusion. 2005 Feb;45(2):133-40</RefSource>
<PMID Version="1">15660820</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001771" MajorTopicYN="N">Blood Banks</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058731" MajorTopicYN="N">Blood Safety</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017848" MajorTopicYN="N">Blood-Borne Pathogens</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4335446</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TTIs screening</Keyword>
<Keyword MajorTopicYN="N">post-donation</Keyword>
<Keyword MajorTopicYN="N">pre-donation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>2</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>2</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25709126</ArticleId>
<ArticleId IdType="pmc">PMC4335446</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000913 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000913 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25709126 |texte= Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25709126" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
This area was generated with Dilib version V0.6.31. |